Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Comparison of concurrent chemoradiotherapy versus induction chemotherapy followed by radiation in patients with nasopharyngeal carcinoma.
Komatsu M, Tsukuda M, Matsuda H, Horiuchi C, Taguch T, Takahashi M, Nishimura G, Mori M, Niho T, Ishitoya J, Sakuma Y, Hirama M, Shiono O.
Anticancer Res. 2012 Feb;32(2):681-6.
Related citations
Treatment evaluation of metastatic lymph nodes after concurrent chemoradiotherapy in patients with head and neck squamous cell carcinoma.
Nishimura G, Matsuda H, Taguchi T, Takahashi M, Komatsu M, Sano D, Sakuma N, Arai Y, Takahashi H.
Anticancer Res. 2012 Feb;32(2):595-600.
Efficacy and feasibility of induction chemotherapy and radiotherapy plus cetuximab in head and neck cancer.
Rampino M, Bacigalupo A, Russi E, Schena M, Lastrucci L, Iotti C, Reali A, Musu A, Balcet V, Piva C, Bustreo S, Munoz F, Ragona R, Corvò R, Ricardi U.
Anticancer Res. 2012 Jan;32(1):195-9.
Inhibition of cyclin D1 by shRNA is associated with enhanced sensitivity to conventional therapies for head and neck squamous cell carcinoma.
Kothari V, Mulherkar R.
Anticancer Res. 2012 Jan;32(1):121-8.
Triple induction chemotherapy and chemoradiotherapy for locally advanced esophageal cancer. A phase II study.
Eisterer W, DE Vries A, Kendler D, Spechtenhauser B, Königsrainer A, Nehoda H, Virgolini I, Lukas P, Bechter O, Wöll E, Ofner D.
Anticancer Res. 2011 Dec;31(12):4407-12.
Mutational screening of RET, HRAS, KRAS, NRAS, BRAF, AKT1, and CTNNB1 in medullary thyroid carcinoma.
Schulten HJ, Al-Maghrabi J, Al-Ghamdi K, Salama S, Al-Muhayawi S, Chaudhary A, Hamour O, Abuzenadah A, Gari M, Al-Qahtani M.
Anticancer Res. 2011 Dec;31(12):4179-83.
ERCC1 expression and outcomes in head and neck cancer treated with concurrent cisplatin and radiation.
Hayes M, Lan C, Yan J, Xie Y, Gray T, Amirkhan RH, Dowell JE.
Anticancer Res. 2011 Dec;31(12):4135-9.
Prevalence of level V metastases in node-positive head and neck squamous cell carcinoma.
Wiegand S, Zimmermann AP, Sesterhenn AM, Werner JA.
Anticancer Res. 2011 Nov;31(11):3959-61.
Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression.
Zhang T, Liu M, Wang C, Lin C, Sun Y, Jin D.
Anticancer Res. 2011 Nov;31(11):3859-63.
Phosphorylation of STAT3 in head and neck cancer requires p38 MAPKinase, whereas phosphorylation of STAT1 occurs via a different signaling pathway.
Riebe C, Pries R, Schroeder KN, Wollenberg B.
Anticancer Res. 2011 Nov;31(11):3819-25.
Selective gelatinase inhibitor peptide is effective in targeting tongue carcinoma cell tumors in vivo.
Suojanen J, Vilen ST, Nyberg P, Heikkilä P, Penate-Medina O, Saris PE, Hagström J, Ranta TM, Salo T, Sorsa T, Reunanen J.
Anticancer Res. 2011 Nov;31(11):3659-64.
Association of caveolin-1 genotypes with nasopharyngeal carcinoma susceptibility in Taiwan.
Tsou YA, Tsai CW, Tsai MH, Chang WS, Li FJ, Liu YF, Chiu CF, Lin CC, Bau DT.
Anticancer Res. 2011 Oct;31(10):3629-32.
Docetaxel plus 5-fluorouracil and cisplatin (DCF) induction chemotherapy for locally advanced borderline-resectable T4 esophageal cancer.
Yokota T, Hatooka S, Ura T, Abe T, Takahari D, Shitara K, Nomura M, Kondo C, Mizota A, Yatabe Y, Shinoda M, Muro K.
Anticancer Res. 2011 Oct;31(10):3535-41.
Effects of acute and chronic hypoxia on the radiosensitivity of gastric and esophageal cancer cells.
Kato Y, Yashiro M, Fuyuhiro Y, Kashiwagi S, Matsuoka J, Hirakawa T, Noda S, Aomatsu N, Hasegawa T, Matsuzaki T, Sawada T, Ohira M, Hirakawa K.
Anticancer Res. 2011 Oct;31(10):3369-75.
Expression of thymidylate synthase and dihydropyrimidine dehydrogenase in primary oral squamous cell carcinoma and corresponding metastases in cervical lymph nodes: association with the metastasis suppressor CD82.
Kawasaki G, Yoshitomi I, Yanamoto S, Yamada S, Mizuno A, Umeda M.
Anticancer Res. 2011 Oct;31(10):3521-6.
Diagnostic value of 16 cellular tumor markers for metastatic thyroid cancer: an immunohistochemical study.
Liang H, Zhong Y, Luo Z, Huang Y, Lin H, Zhan S, Xie K, Li QQ.
Anticancer Res. 2011 Oct;31(10):3433-40.
Differential expression of apoptosis, cell cycle regulation and intermediate filament genes in oral squamous cell carcinomas associated with toombak use in Sudan.
Jalouli MM, Jalouli J, Sapkota D, Ibrahim SO, Sand L, Hirsch JM.
Anticancer Res. 2011 Oct;31(10):3345-51.
Biodistribution of 131I-labeled anti-CK8 monoclonal antibody in HNSCC in xenotransplanted SCID mice.
Andratschke M, Luebbers CW, Johannson V, Schmitt B, Mack B, Zeidler R, Lang S, Wollenberg B, Gildehaus FJ.
Anticancer Res. 2011 Oct;31(10):3315-21.
TGF-beta regulation of focal adhesion proteins and motility of premalignant oral lesions via protein phosphatase 1.
Walsh JE, Young MR.
Anticancer Res. 2011 Oct;31(10):3159-64.
Cyclin B1 expression and p53 status in squamous cell carcinomas of the head and neck.
Hoffmann TK, Trellakis S, Okulicz K, Schuler P, Greve J, Arnolds J, Bergmann C, Bas M, Lang S, Lehnerdt G, Brandau S, Mattheis S, Scheckenbach K, Finn OJ, Whiteside TL, Sonkoly E.
Anticancer Res. 2011 Oct;31(10):3151-7.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on